Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
741.39B | 764.70B | 739.26B | 608.33B | 492.62B | Gross Profit |
223.94B | 188.75B | 228.32B | 203.05B | 168.84B | EBIT |
66.17B | 28.25B | 91.73B | 88.46B | 64.05B | EBITDA |
99.74B | 54.13B | 112.73B | 104.95B | 78.39B | Net Income Common Stockholders |
43.69B | 11.71B | 64.77B | 62.02B | 47.73B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
196.65B | 162.72B | 71.06B | 148.64B | 143.44B | Total Assets |
1.06T | 1.10T | 1.01T | 812.88B | 674.56B | Total Debt |
19.89B | 203.62B | 96.46B | 16.45B | 19.74B | Net Debt |
-176.75B | 76.81B | 42.64B | -104.94B | -67.29B | Total Liabilities |
180.60B | 323.65B | 254.97B | 149.55B | 98.82B | Stockholders Equity |
868.16B | 769.25B | 746.34B | 657.86B | 571.27B |
Cash Flow | Free Cash Flow | |||
219.24B | 5.34B | -163.60B | 14.68B | 12.90B | Operating Cash Flow |
237.09B | 44.43B | -103.66B | 64.54B | 57.31B | Investing Cash Flow |
-25.62B | -37.68B | -27.89B | -42.91B | -30.51B | Financing Cash Flow |
-191.28B | 80.97B | 52.63B | -23.04B | -22.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $7.05B | 18.01 | 26.98% | 2.09% | 4.02% | 42.77% | |
71 Outperform | $10.24B | 22.65 | 34.83% | 1.59% | -2.29% | -14.49% | |
71 Outperform | $8.05B | 15.33 | 8.74% | 1.60% | -3.70% | 72.77% | |
68 Neutral | $4.66B | 14.36 | 11.85% | 2.04% | -3.69% | -11.76% | |
66 Neutral | $16.57B | 16.59 | 19.15% | 2.52% | -0.88% | 0.04% | |
64 Neutral | $9.50B | 26.07 | 4.03% | 5.33% | -3.04% | ― | |
64 Neutral | $4.27B | 11.80 | 5.31% | 249.79% | 4.07% | -9.02% |